Categories AlphaGraphs, Earnings, Health Care
JNJ Earnings: Key quarterly highlights from Johnson & Johnson’s Q3 2025 financial results
Johnson & Johnson (NYSE: JNJ) reported its third quarter 2025 earnings results today.
Reported sales increased 6.8% year-over-year to $24 billion. Operational sales were up 5.4%.
GAAP net earnings rose 91% to $5.2 billion, or $2.12 per share, compared to last year. Adjusted EPS grew 16% to $2.80.
Revenue and earnings beat estimates.
The company raised its sales guidance for the full year of 2025 and now expects reported sales to be $93.5-93.9 billion. It reaffirmed its guidance for adjusted EPS, which is expected to be $10.80-10.90.
In a separate release, JNJ announced its intent to separate its Orthopaedics business to improve strategic focus and drive shareholder value. The transaction would create a standalone orthopaedics business named DePuy Synthes. The company has appointed Namal Nawana as Worldwide President, DePuy Synthes, effective immediately. It expects to complete this transaction within 18 to 24 months, based on certain conditions.
JNJ also declared a cash dividend of $1.30 per common share for the fourth quarter of 2025, payable on December 9, 2025 to shareholders of record as of November 25, 2025.
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
CRM Earnings: Salesforce Q3 revenue up 8.6%; earnings beat estimates
Customer relationship management platform Salesforce, Inc. (NYSE: CRM) on Wednesday reported stronger-than-expected earnings for the third quarter of fiscal 2026. Revenues increased 8.6%. Adjusted net income increased to $3.25 per
Cloud Growth and AI Demand in focus as Oracle gears up for Q2 earnings
Technology giant Oracle Corporation (NYSE: ORCL) began the new fiscal year on a mixed note, reporting Q1 FY26 results that grew year over year but fell short of market expectations.
Key takeaways from Macy’s (M) Q3 2025 earnings report
Shares of Macy’s, Inc. (NYSE: M) gained over 1% in mid-day trade on Wednesday after falling earlier in the day despite the company delivering better-than-expected results for the third quarter
